Gastric cancer – Basic Information

Go back

Gastric cancer, also known as stomach cancer, is a disease where abnormal cells begin to grow uncontrollably in the stomach lining and can eventually spread to other organs. Although it was once a leading cause of cancer death, its incidence has been declining in many regions, though it remains one of the most common cancers worldwide, particularly in East Asia.

Epidemiology of Gastric Cancer

Gastric cancer ranks as the fifth most frequently diagnosed cancer globally and is the fourth leading cause of cancer deaths worldwide. The disease shows striking differences in how common it is depending on where people live. In regions like East Asia—especially Japan and Mongolia—and parts of Eastern Europe, gastric cancer occurs much more frequently than in other parts of the world. In contrast, countries in Northern Europe and North America, including the United States, report much lower rates, similar to those seen in many African regions.[1][2]

In the United States specifically, gastric cancer accounts for only about 1.5% of all newly diagnosed cancers each year. The overall number of new cases has been steadily declining over the past several decades, dropping by approximately 1.5% annually over the last ten years. This downward trend is believed to be linked to improved food storage methods, such as refrigeration, which has reduced reliance on preserved and salted foods. Despite this encouraging decline, an estimated 30,300 new cases and 10,780 deaths from gastric cancer are expected in the U.S. in 2025.[1][5][11]

However, not all age groups are experiencing the same trends. While older adults continue to see declining rates, younger adults—those between 25 and 39 years old—have seen an increase in gastric cancer diagnoses since the late 1970s. The reasons behind this rise in younger populations are not yet fully understood and require further investigation. Additionally, gastric cancer does not affect all demographic groups equally. In the United States, the disease is more common among Hispanic, Black, and Asian/Pacific Islander populations compared to white Americans.[3][11][21]

Men are nearly twice as likely as women to develop gastric cancer. The average age at diagnosis is 68, with about 60% of cases occurring in people aged 65 or older. This means that gastric cancer primarily affects older individuals, though it can occur at any age.[1][3]

Causes of Gastric Cancer

Gastric cancer develops when a genetic mutation—a change in the DNA of stomach cells—causes those cells to grow out of control instead of dying off as they normally would. Over time, these rapidly multiplying cells accumulate and form a tumor. If left untreated, the cancer cells can invade deeper layers of the stomach wall and eventually spread to nearby organs such as the liver, pancreas, or lungs, or even to distant parts of the body through a process called metastasis.[2][3]

Researchers do not know exactly what triggers these genetic mutations, but they have identified several factors that significantly increase the risk of developing gastric cancer. One of the most important is infection with a bacterium called Helicobacter pylori, or H. pylori. This common infection can inflame and damage the stomach lining over many years, leading to changes that may eventually turn into cancer. Many people with H. pylori infections do not have symptoms, but some develop chronic inflammation of the stomach, known as atrophic gastritis, which is a known precursor to cancer.[1][3][11]

Another virus, the Epstein-Barr virus, has also been associated with an increased risk of gastric cancer. Certain chronic conditions such as gastroesophageal reflux disease (GERD)—where stomach acid frequently backs up into the esophagus—can also contribute to cancer development over time. People with a history of stomach ulcers, stomach polyps, or a condition called pernicious anemia (where the body cannot absorb enough vitamin B12) are also at higher risk.[1][11]

Some inherited genetic conditions also raise the likelihood of developing gastric cancer. These include familial adenomatous polyposis, Lynch syndrome, and hereditary diffuse gastric cancer syndrome, among others. Having a close family member who has had gastric cancer increases your own risk, even if no specific genetic syndrome has been identified.[1][11]

⚠️ Important
Most stomach cancers—about 90% to 95%—are a type called adenocarcinoma, which begins in the mucus-producing cells of the stomach’s innermost lining. Other, less common types include gastrointestinal stromal tumors and certain types of lymphoma. Understanding the specific type of gastric cancer is important because it influences treatment decisions and prognosis.

Risk Factors for Gastric Cancer

Several habits, behaviors, and medical conditions can increase a person’s risk of developing gastric cancer. One of the most significant controllable risk factors is diet. Eating a lot of salty, smoked, pickled, or highly processed foods has been linked to higher rates of stomach cancer. On the other hand, a diet that is low in fresh fruits and vegetables may also increase risk, as these foods contain nutrients and compounds that help protect the stomach lining from damage.[1][11]

Smoking cigarettes, vaping, or chewing tobacco significantly raises the risk of gastric cancer. Similarly, drinking too much alcohol over a long period of time can damage the stomach lining and contribute to cancer development. Obesity is another modifiable risk factor; carrying excess weight has been associated with a higher likelihood of developing several types of cancer, including gastric cancer.[1][3][21]

Occupational and environmental exposures also play a role. People who work with or are frequently exposed to substances like coal, metal, or rubber may be at increased risk. These exposures can damage cells over time and contribute to the development of cancer.[1]

Certain pre-existing medical conditions can also raise risk. Chronic inflammation of the stomach lining, especially a condition called intestinal metaplasia—where normal stomach cells are replaced by cells that resemble those of the intestines—is a known risk factor. People with autoimmune atrophic gastritis, where the immune system attacks the stomach’s own cells, are also at elevated risk.[1][11]

Finally, advanced age is a major non-modifiable risk factor. The majority of gastric cancer cases occur in people over 65, and the disease is more common in men than in women. Ethnicity also plays a role, with higher rates observed in certain populations, as previously mentioned.[1][3]

Symptoms of Gastric Cancer

One of the challenges with gastric cancer is that it often does not cause noticeable symptoms in its early stages. When symptoms do appear, they are frequently vague and can easily be mistaken for other, less serious digestive problems. This lack of early warning signs means that many people are not diagnosed until the cancer has progressed to a more advanced stage, which complicates treatment and reduces survival rates.[1][3]

Common early symptoms of gastric cancer include unexplained weight loss and persistent stomach pain, often felt above the belly button. Many people experience frequent indigestion, heartburn, and a feeling of fullness or bloating even after eating only a small amount of food. Loss of appetite is also very common, and some people feel too full to eat regular-sized meals.[1][3]

As the disease progresses, symptoms can become more severe. People may develop nausea and vomiting, sometimes bringing up blood. Stools may appear black or tarry due to bleeding in the stomach. Difficulty swallowing can occur if the tumor is located near the junction where the esophagus meets the stomach. Fatigue and weakness are also common, often resulting from anemia caused by slow, chronic bleeding from the tumor.[1][3]

In some cases, advanced gastric cancer may cause a noticeable mass in the abdomen that a doctor can feel during a physical exam. Jaundice—a yellowing of the skin and eyes—can develop if the cancer spreads to the liver.[1][3]

Many of these symptoms overlap with those of other, more common conditions such as ulcers or gastritis. However, if symptoms persist or worsen, it is important to see a healthcare provider for evaluation. Early detection, even when symptoms are vague, can improve outcomes significantly.[1][3]

Prevention of Gastric Cancer

While not all cases of gastric cancer can be prevented, there are several steps people can take to reduce their risk. One of the most effective measures is treating H. pylori infection if it is detected. Antibiotics can eliminate this bacterium and reduce the chronic inflammation and damage to the stomach lining that it causes. In regions where H. pylori is common, public health programs aimed at identifying and treating infections have contributed to lower rates of gastric cancer.[1][21]

Dietary changes can also play a significant role in prevention. Eating a diet rich in fresh fruits and vegetables provides the body with antioxidants and other protective compounds that help guard against cancer. Reducing intake of salty, smoked, pickled, and processed foods can lower risk. Using refrigeration for food storage instead of relying on salting or smoking as preservation methods is one reason gastric cancer rates have declined in many developed countries.[1][11][21]

Avoiding tobacco in all its forms—cigarettes, cigars, chewing tobacco, and vaping—is another important preventive measure. Similarly, limiting alcohol consumption can reduce the risk of stomach damage and cancer development. Maintaining a healthy weight through regular physical activity and a balanced diet also helps lower risk.[1][21]

For people with a family history of gastric cancer or known genetic syndromes that increase risk, regular screening and close monitoring by a healthcare provider may be recommended. While there is no standard screening test for gastric cancer in the United States, people at high risk may benefit from periodic endoscopy—a procedure in which a flexible tube with a camera is inserted through the mouth to visually inspect the stomach lining.[2][8]

In countries where gastric cancer is much more common, such as Japan and South Korea, mass screening programs using endoscopy have been successful in detecting cancer at earlier, more treatable stages. These programs have contributed to improved survival rates in those regions.[2][13]

Pathophysiology of Gastric Cancer

The development of gastric cancer is a gradual process that typically unfolds over many years. It begins with small changes in the DNA of cells in the stomach lining. These changes, or mutations, cause cells to multiply more rapidly than they should and to avoid the normal process of cell death. As these abnormal cells accumulate, they form clusters and eventually develop into a tumor.[1][3]

In the earliest stages, cancer cells are confined to the innermost layer of the stomach, called the mucosa. This stage is sometimes referred to as carcinoma in situ. At this point, the cancer has not yet invaded deeper layers of the stomach wall and is often easier to treat successfully. However, because there are usually no symptoms at this stage, it is rarely detected unless a person undergoes screening for other reasons.[2][9]

As the cancer progresses, it grows deeper into the stomach wall, invading the muscular layers and eventually reaching the outer layer. The tumor may also spread to nearby lymph nodes, which are small structures that help filter out harmful substances. Once cancer cells reach the lymph nodes, they can travel through the lymphatic system to other parts of the body.[2][3]

In advanced stages, gastric cancer can metastasize to distant organs such as the liver, lungs, or bones. This spread significantly complicates treatment and reduces the chances of a cure. The five-year survival rate for gastric cancer that has spread to distant sites is much lower than for cancer that is caught early and confined to the stomach.[2][11]

Gastric cancers are often classified based on their location in the stomach and their appearance under a microscope. In the United States, most gastric cancers develop in the upper part of the stomach, near where it connects to the esophagus. This area is called the gastroesophageal junction. In other parts of the world, cancer more commonly develops in the lower part of the stomach, known as the antrum or body.[1][2]

Under the microscope, gastric adenocarcinomas are divided into two main types: intestinal and diffuse. Intestinal-type cancers tend to grow more slowly and have cells that look relatively similar to normal stomach cells. Diffuse-type cancers, on the other hand, grow and spread more quickly and have cells that look very different from normal cells. Diffuse cancers are generally harder to treat and have a poorer prognosis.[2][5]

⚠️ Important
The prognosis for gastric cancer depends heavily on how far it has spread at the time of diagnosis. Early-stage gastric cancer that is confined to the stomach lining has a much better prognosis than cancer that has invaded deeper layers or spread to lymph nodes and distant organs. This is why early detection, though challenging, is so important for improving survival rates.

Ongoing Clinical Trials on Gastric cancer

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia France Germany +6
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Hungary Italy +1
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Ireland
  • Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Denmark
  • Study on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany

References

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/symptoms-causes/syc-20352438

https://www.cancer.gov/types/stomach

https://my.clevelandclinic.org/health/diseases/15812-stomach-cancer

https://www.cancer.org.au/cancer-information/types-of-cancer/stomach-cancer

https://www.ncbi.nlm.nih.gov/books/NBK459142/

https://health.ucdavis.edu/cancer/services-specialties/stomach-cancer/

https://www.cancerresearchuk.org/about-cancer/stomach-cancer

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.cancer.gov/types/stomach/treatment

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01451-3

https://www.ncbi.nlm.nih.gov/books/NBK65766/

https://www.mskcc.org/cancer-care/types/stomach-gastric/treatment

https://www.cancerresearch.org/immunotherapy-by-cancer-type/stomach-cancer

https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

https://www.cancer.gov/types/stomach/coping

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/living-with/coping

https://www.cancercare.org/publications/224-coping_with_gastric_cancer

https://www.accc-cancer.org/acccbuzz/blog-post-template/accc-buzz/2015/02/02/8-strategies-to-help-gastric-cancer-patients-cope-with-nutrition-problems-during-treatment

https://www.cancer.org/cancer/types/stomach-cancer/after-treatment/follow-up.html

https://cancer.ca/en/cancer-information/cancer-types/stomach/supportive-care/nutrition-and-stomach-cancer

https://www.medstarhealth.org/blog/toby-keith-stomach-cancer

https://www.foxchase.org/blog/2017-2811-life-without-a-stomach-staying-healthy-after-surgery

https://health.clevelandclinic.org/coping-with-stomach-cancer-changes

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can gastric cancer be cured?

Yes, gastric cancer can be cured, especially if it is detected early. For cancers that have not spread beyond the stomach, surgery to remove part or all of the stomach, often combined with chemotherapy, can offer a chance of cure. However, if the cancer has spread to distant organs, cure is rarely possible, and treatment focuses on prolonging life and improving quality of life.

Is gastric cancer hereditary?

Gastric cancer can be hereditary in some cases. Several inherited genetic syndromes, such as hereditary diffuse gastric cancer syndrome, Lynch syndrome, and familial adenomatous polyposis, increase the risk. Having a family history of gastric cancer, especially if diagnosed at a young age or in multiple family members, also raises your risk. However, most gastric cancers are not directly inherited and result from a combination of environmental and lifestyle factors.

What are the first signs of stomach cancer?

Early-stage stomach cancer often causes no noticeable symptoms. When symptoms do appear, the most common early signs include unexplained weight loss, persistent stomach pain or discomfort, loss of appetite, frequent indigestion or heartburn, and a feeling of fullness after eating only small amounts of food. Because these symptoms are similar to many less serious digestive conditions, it’s important to see a doctor if they persist.

Is there a screening test for gastric cancer?

There is no standard screening test for gastric cancer in the United States, where the disease is relatively uncommon. However, in countries with high rates of gastric cancer, such as Japan and South Korea, screening programs using endoscopy are common and have been effective in detecting cancer early. In the U.S., people at high risk due to family history or genetic syndromes may benefit from periodic endoscopy.

Can you live without a stomach?

Yes, it is possible to live without a stomach. In cases where the entire stomach must be removed due to cancer, surgeons connect the esophagus directly to the small intestine. This allows food to pass through the digestive system, though patients must eat smaller, more frequent meals and may need nutritional supplements to ensure they absorb enough nutrients. With careful dietary management, many people live healthy lives after a total gastrectomy.

🎯 Key takeaways

  • Gastric cancer is the fifth most common cancer worldwide but is relatively rare in the United States, accounting for only 1.5% of new cancer diagnoses annually.
  • Men are nearly twice as likely as women to develop gastric cancer, and the disease is more common in people over 65, though rates are rising among younger adults.
  • Infection with H. pylori bacteria is one of the most significant risk factors for gastric cancer, and treating this infection can reduce cancer risk.
  • Early-stage gastric cancer often causes no symptoms, which is why many cases are not diagnosed until the disease has advanced and become harder to treat.
  • A diet high in salty, smoked, or processed foods increases gastric cancer risk, while eating plenty of fresh fruits and vegetables can help protect against the disease.
  • Avoiding tobacco and limiting alcohol consumption are important lifestyle changes that can lower your risk of developing gastric cancer.
  • Most gastric cancers are adenocarcinomas that begin in the stomach’s innermost lining and can spread to nearby lymph nodes and distant organs if not treated early.
  • In countries with high rates of gastric cancer, screening programs using endoscopy have been successful in detecting cancer early and improving survival rates.